Your browser doesn't support javascript.
loading
Exploring the interplay of psychiatric symptoms, antipsychotic medications, side effects, employment status, and quality of life in Chronic Schizophrenia.
Zhou, Dan-Na; Yang, Xue; Wang, Wen; Jin, Wen-Qing; Tang, Yi-Lang; Zheng, Zhi; Ren, Yanping.
Affiliation
  • Zhou DN; Beijing Key Laboratory of Mental Disorders, Beijing Anding Hospital, National Clinical Research Center for Mental Disorders & National Center for Mental Disorders, Capital Medical University, Beijing, China.
  • Yang X; Advanced Innovation Center for Human Brain Protection, Capital Medical University, Beijing, China.
  • Wang W; The First Psychiatric Hospital of Harbin, Harbin, Heilongjiang Province, China.
  • Jin WQ; Beijing Key Laboratory of Mental Disorders, Beijing Anding Hospital, National Clinical Research Center for Mental Disorders & National Center for Mental Disorders, Capital Medical University, Beijing, China.
  • Tang YL; Advanced Innovation Center for Human Brain Protection, Capital Medical University, Beijing, China.
  • Zheng Z; Beijing Key Laboratory of Mental Disorders, Beijing Anding Hospital, National Clinical Research Center for Mental Disorders & National Center for Mental Disorders, Capital Medical University, Beijing, China.
  • Ren Y; Advanced Innovation Center for Human Brain Protection, Capital Medical University, Beijing, China.
BMC Psychiatry ; 24(1): 484, 2024 Jul 02.
Article in En | MEDLINE | ID: mdl-38956530
ABSTRACT

BACKGROUND:

Many factors contribute to quality of life (QoL) in patients with schizophrenia, yet limited research examined these factors in patients in China. This cross-sectional study explores subjective QoL and its associated factors in patients.

METHODS:

The QoL was assessed using the Schizophrenia Quality of Life Scale (SQLS). Clinical symptoms were evaluated using the Brief Psychiatric Rating Scale (BPRS) and seven factors were extracted. Patient Health Questionnaire-9 (PHQ-9), and Generalized Anxiety Disorder Scale (GAD-7) were used to assess depression and anxiety. Cognitive impairment was assessed using the Ascertain Dementia 8 (AD8). The Treatment Emergent Symptom Scale (TESS) and Rating Scale for Extrapyramidal Side Effects (RSESE) were used to evaluate the side effects of medications.

RESULTS:

We recruited 270 patients (male142,52.6%, mean age41.9 ± 9.4 years). Positive correlations were observed between SQLS and its subdomains with the total score of BPRS, PHQ-9, GAD-7, AD8, TESS, and RSESE (all P < 0.005). Patients who were taking activating second-generation antipsychotics (SGAs) had lower scores on total SQLS, Motivation/ Energy domain of SQLS (SQLS-ME) as well as Symptoms/ Side effects domain of SQLS (SQLS-SS) compared to those taking non-activating SGAs (all P < 0.005). Multiple regression analysis showed that depressive/ anxiety symptoms and cognitive impairment had significant negative effects on QoL (P ≤ 0.001), while activating SGAs had a positive effect (P < 0.005). Blunted affect and unemployment were inversely associated with the motivation/energy domain (P < 0.001).

CONCLUSION:

Our findings emphasize the important role of depression/anxiety symptoms and cognitive impairment in the QoL of patients with chronic schizophrenia. Activating SGAs and employment may improve the QoL of these individuals. TRIAL REGISTRATION This protocol was registered at chictr.org.cn (Identifier ChiCTR2100043537).
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Quality of Life / Schizophrenia / Antipsychotic Agents / Employment Limits: Adult / Female / Humans / Male / Middle aged Country/Region as subject: Asia Language: En Journal: BMC Psychiatry Journal subject: PSIQUIATRIA Year: 2024 Type: Article Affiliation country: China

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Quality of Life / Schizophrenia / Antipsychotic Agents / Employment Limits: Adult / Female / Humans / Male / Middle aged Country/Region as subject: Asia Language: En Journal: BMC Psychiatry Journal subject: PSIQUIATRIA Year: 2024 Type: Article Affiliation country: China